Faculty Profile
Dhara D. Surati
Clinical Associate Professor
Pharmacy Practice and Translational Research
Office:
91破解版 College of Pharmacy
Health 2, Room 4014
4349 Martin Luther King Boulevard
Houston, TX 77204-5039
Contact: dnshah@central.uh.edu - Office: 832-842-8346 - Fax: 832-842-8383
Research/Academic Interests:
- Skills labs-based teaching
- Active learning
- Infectious diseases
- Scholarship of teaching and learning
- Doctor of Pharmacy, Summa Cum Laude, 91破解版 College of Pharmacy, Houston, Texas
- Clinical Research Curriculum, University of Texas Medical School, Houston, Texas, 2009 - present
- 15th Annual Fellows Course in Hospital Epidemiology and Infection Control, July 6鈥�8, 2011, Johns Hopkins University, Baltimore, Maryland
- Infectious Diseases Fellow, 91破解版-College of Pharmacy, Houston, Texas, Mentors: Kevin W. Garey, Pharm.D., M.S., and Herbert L. DuPont, M.D.
- PGY-1 Pharmacy Practice Resident, Memorial Hermann-Texas Medical Center, Houston, Texas, Program Director: Bradley Domonoske, Pharm.D., BCPS
- Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect. 2018.
- Sofjan AK, Mitchell A, Shah DN, et al. Rezafungin (CD101), a next generation echinocandin. J Glob Antimicrob Resist. 2018.
- Das J, Fernandez J, Shah D, et al. Case-based studies in teaching medicinal chemistry in PharmD curriculum. Curr Pharm Teach Learn. 10(1):85-89.
- Shah DN, Chan FS, Kachru N, et al. A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus. 2016; 5(1):1224.
- Shah DN, Aitken SL, Barragan LF, et al. Economic burden of primary compared with recurrent Clostridium difficile.
- Garey KW, Aitken SL, Gschwind L, et al. Development and validation of a Clostridium difficile health-related quality-of-life questionnaire. J Clin Gastroenterol. 2016; 50(8):631-7.
- Kilic A, Alam MJ, Tisdel NL, Shah DN, et al. Multiplex real-time PCR for Clostridium difficile from stool samples. Ann Lab Med. 2015; 35(3):306-13.
- Na X, Martin AJ, Sethi S, et al. A clinical prediction tool for severe Clostridium difficile infection. PLoS One. 2015; 10(4):eCollection 2015.
- Aitken SL, Joseph TB, Shah DN, et al. Healthcare resource utilization for recurrent C. difficile in a university hospital. PLoS One. 2014; 9(7):e102848.
- Aitken SL, Beyda ND, Shah DN, et al. Clinical practice patterns and antifungal stewardship. Ann Pharmacother. 2014.
- Jardin CG, Palmer HR, Shah DN, et al. Treatment outcomes before vs. after implementation of C. difficile treatment policy. J Hosp Infect. 2013; 85(1):28-32.
- Shah DN, Bhatt NS, Welch JK, et al. Defining renal dysfunction for C. difficile severity in different settings. J Hosp Infect. 2013; 83(4):294-9.
- Beyda ND, Chuang SH, Alam MJ, Shah DN, et al. Candida famata bloodstream infections: case series and review. J Antimicrob Chemother. 2013; 68(2):438-43.
- Shah DN, Yau R, Lasco TM, et al. Impact of inappropriate fluconazole dosing in candidemia. Antimicrob Agents Chemother. 2012; 56(6):3239-43.
- Le F, Arora V, Shah DN, et al. Evaluation of oral vancomycin for severe C. difficile: Implications for stewardship. Pharmacother. 2012; 32(2):129-34.
Awards & Honors
- Excellence in Teaching, 91破解版 College of Pharmacy, 2021
- Faculty Preceptor of the Year Award, 91破解版 College of Pharmacy, 2016